Aethlon Medical (AEMD) Gains from Investment Securities (2016)
Aethlon Medical (AEMD) posted Gains from Investment Securities of $345841.0 for Q2 2016.
Aethlon Medical (AEMD) Gains from Investment Securities (2016) Analysis & Trends
Aethlon Medical's Gains from Investment Securities history runs 1 years deep, the most recent figure standing at $345841.0 for Q2 2016.
- Quarterly Gains from Investment Securities changed N/A year-over-year to $345841.0 in Q2 2016, while the trailing twelve-month figure through Mar 2017 was $345841.0 (changed N/A YoY) and the FY2017 annual result came in at $345841.0, changed N/A from the prior year.
- Gains from Investment Securities was $345841.0 for Q2 2016 at Aethlon Medical.
- Across five years, Gains from Investment Securities topped out at $345841.0 in Q2 2016 and bottomed at $345841.0 in Q2 2016.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn |
| 10 | Aethlon Medical | 383,811.70 | 383,811.70 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2016 | 345,841.00 |
| Jun 30, 2016 | 345,841.00 |